Retour à la listeCompany

Ouvrir une nouvelle ère dans la recherche de médicaments contre la douleur et les maladies oculaires

2020-02-07

[Sisa Today, Reporter Haewon Jeon] We go to the hospital because we are, so to speak, 'in pain.' The goal is to identify the cause of 'pain' — the body's distress signal — and receive appropriate treatment. Cependant, douleur chronique that follows like a shadow even after recovery from illness endlessly torments patients and plunges them into suffering.

The World Health Organization (WHO) classifies such douleur chronique not as a byproduct of illness but as a 'disease' in its own right. In other words, 'pain' is not just a symptom but a condition that requires treatment.

le PDG Yongho Kim of RudaCure Inc. (www.rudacure.com), an assistant professor in the Department of Physiology at Gachon University College of Medicine, has dedicated himself to fundamental research on 'pain' that goes beyond conventional soulagement de la douleur concepts, stepping up to present a new paradigm for Korea's développement de nouveaux médicaments industrie.

L'entreprise's diversified business areas include ▲ CRPS (Complex Regional Pain Syndrome) ▲ douleur neuropathique ▲ cancer-induced pain ▲ ocular diseases (sécheresse oculaire, macular degeneration), and l'entreprise is developing solutions in all these areas.

Retour à la liste